| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |